Results 211 to 220 of about 40,704 (273)

Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPs. [PDF]

Molecules
Shriwas P, Revnew A, Roo S, Bender A, Miller K, Hadad CM, Lane TR, Ekins S, McElroy CA.   +8 more
europepmc   +1 more source

Association between <i>CYP2C19</i> polymorphism and proton pump inhibitors adverse drug reactions: a narrative review. [PDF]

Front Pharmacol
Ibrahim A, Yusuff K, Awaisu A, Elewa H.
europepmc   +1 more source

Mavacamten maintenance dose determination: insights into individualised therapy for hypertrophic cardiomyopathy. [PDF]

Open Heart
Scholtz S, Coppée C, Mohemed K, Potratz M, Sequeira V, Rudolph V, Scholtz W, Reil JC.   +7 more
europepmc   +1 more source

Pharmacokinetic Profiles of Lansoprazole in Patients With Morbid Obesity Post-Roux-en-Y Gastric Bypass Surgery. [PDF]

Clin Transl Sci
Udomsawaengsup S, Chantawibul S, Boonyuen N, Panyavorakhunchai S, Kachornvitaya P, Wisanuyothin W, Somvanapanich P, Lertwatthiphong W, Tanathitiphuwarat N, Chariyavilaskul P.   +9 more
europepmc   +1 more source

Cytochrome P450 17 (CYP17), CYP2C19*2, CYP2C19*3 Gene Polymorphisms and Gastrointestinal Cancer Risk in Rural Maharashtra: A Hospital based Case-Control Study. [PDF]

Asian Pac J Cancer Prev
Datkhile KD, More AL, Patil MN, Gudur RA, Gudur AK.   +4 more
europepmc   +1 more source

Risk of major adverse cardiovascular events in CYP2C19 LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta-analysis. [PDF]

Clin Transl Sci
Biswas M, Murad MA, Ershadian M, Kali MSK, Sukasem C.   +4 more
europepmc   +1 more source

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome. [PDF]

Eur Heart J Cardiovasc Pharmacother
van den Broek WWA, Azzahhafi J, Chan Pin Yin DRPP, van der Sangen NMR, Sivanesan S, Dijksman LM, Walhout RJ, Tjon Joe Gin M, Breet NJ, Langerveld J, Vlachojannis GJ, van Bommel RJ, Appelman Y, van Schaik RHN, Henriques JPS, Kikkert WJ, Ten Berg JM.   +16 more
europepmc   +1 more source

Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke: A Nonrandomized Clinical Trial.

JAMA Netw Open
Jung YH, Song TJ, Kim J, Park HK, Han SW, Kim YD, Park JH, Cha JK, Park HY, Sohn SI, Yu S, Lee JH, Shin DH, Kim EG, Lee HS, Lee KY, PLATELET Trial Investigators.   +16 more
europepmc   +1 more source

Predictive Biomarkers and Personalized Therapy: Use of Pharmacogenetic Testing in a Scandinavian Perspective. [PDF]

Basic Clin Pharmacol Toxicol
Westergaard N, Lund TM, Vermehren C.
europepmc   +1 more source

Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction. [PDF]

Open Heart
Burford E, Kasolo Y, Draper J, Sheikh N, Carr-White G, de Marvao A, Dungu JN, Bastiaenen R, Cooper RM.   +8 more
europepmc   +1 more source